These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
588 related articles for article (PubMed ID: 25524829)
21. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells. Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957 [TBL] [Abstract][Full Text] [Related]
22. Enantiomer-specific bioactivities of peptidomimetic analogues of mastoparan and mitoparan: characterization of inverso mastoparan as a highly efficient cell penetrating peptide. Jones S; Howl J Bioconjug Chem; 2012 Jan; 23(1):47-56. PubMed ID: 22148546 [TBL] [Abstract][Full Text] [Related]
23. Effect of Ala replacement with Aib in amphipathic cell-penetrating peptide on oligonucleotide delivery into cells. Wada S; Hashimoto Y; Kawai Y; Miyata K; Tsuda H; Nakagawa O; Urata H Bioorg Med Chem; 2013 Dec; 21(24):7669-73. PubMed ID: 24216093 [TBL] [Abstract][Full Text] [Related]
24. Quantifying molecular partition of cell-penetrating peptide-cargo supramolecular complexes into lipid membranes: optimizing peptide-based drug delivery systems. Freire JM; Veiga AS; de la Torre BG; Andreu D; Castanho MA J Pept Sci; 2013 Apr; 19(4):182-9. PubMed ID: 23322613 [TBL] [Abstract][Full Text] [Related]
25. Decoding the proteome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for cell-penetrating peptides involved in pathogenesis or applicable as drug delivery vectors. Hemmati S; Behzadipour Y; Haddad M Infect Genet Evol; 2020 Nov; 85():104474. PubMed ID: 32712315 [TBL] [Abstract][Full Text] [Related]
26. Cell penetrating peptides: A concise review with emphasis on biomedical applications. Derakhshankhah H; Jafari S Biomed Pharmacother; 2018 Dec; 108():1090-1096. PubMed ID: 30372809 [TBL] [Abstract][Full Text] [Related]
27. Identification of a novel cell-penetrating peptide targeting human glioblastoma cell lines as a cancer-homing transporter. Higa M; Katagiri C; Shimizu-Okabe C; Tsumuraya T; Sunagawa M; Nakamura M; Ishiuchi S; Takayama C; Kondo E; Matsushita M Biochem Biophys Res Commun; 2015 Feb; 457(2):206-12. PubMed ID: 25562654 [TBL] [Abstract][Full Text] [Related]
28. Cell-Penetrating Peptides as Carriers for Oral Delivery of Biopharmaceuticals. Kristensen M; Nielsen HM Basic Clin Pharmacol Toxicol; 2016 Feb; 118(2):99-106. PubMed ID: 26525297 [TBL] [Abstract][Full Text] [Related]
29. Measuring Intracellular Secondary Structure of a Cell-Penetrating Peptide in Situ. Fleissner F; Pütz S; Schwendy M; Bonn M; Parekh SH Anal Chem; 2017 Nov; 89(21):11310-11317. PubMed ID: 29045142 [TBL] [Abstract][Full Text] [Related]
30. Nonhemolytic Cell-Penetrating Peptides: Site Specific Introduction of Glutamine and Lysine Residues into the α-Helical Peptide Causes Deletion of Its Direct Membrane Disrupting Ability but Retention of Its Cell Penetrating Ability. Kim S; Hyun S; Lee Y; Lee Y; Yu J Biomacromolecules; 2016 Sep; 17(9):3007-15. PubMed ID: 27442521 [TBL] [Abstract][Full Text] [Related]
31. On the importance of electrostatic interactions between cell penetrating peptides and membranes: a pathway toward tumor cell selectivity? Jobin ML; Alves ID Biochimie; 2014 Dec; 107 Pt A():154-9. PubMed ID: 25107405 [TBL] [Abstract][Full Text] [Related]
32. Peptide-mediated protein delivery-which pathways are penetrable? Räägel H; Säälik P; Pooga M Biochim Biophys Acta; 2010 Dec; 1798(12):2240-8. PubMed ID: 20170627 [TBL] [Abstract][Full Text] [Related]
33. Photodamage of lipid bilayers by irradiation of a fluorescently labeled cell-penetrating peptide. Meerovich I; Muthukrishnan N; Johnson GA; Erazo-Oliveras A; Pellois JP Biochim Biophys Acta; 2014 Jan; 1840(1):507-15. PubMed ID: 24135456 [TBL] [Abstract][Full Text] [Related]
34. A real-time assay for cell-penetrating peptide-mediated delivery of molecular cargos. Gentry SB; Nowak SJ; Ni X; Hill SA; Wade LR; Clark WR; Keelaghan AP; Morris DP; McMurry JL PLoS One; 2021; 16(9):e0254468. PubMed ID: 34473728 [TBL] [Abstract][Full Text] [Related]
35. Cellular uptake and in vivo distribution of polyhistidine peptides. Iwasaki T; Tokuda Y; Kotake A; Okada H; Takeda S; Kawano T; Nakayama Y J Control Release; 2015 Jul; 210():115-24. PubMed ID: 25980622 [TBL] [Abstract][Full Text] [Related]
36. Characterization of a Cell-Penetrating Peptide with Potential Anticancer Activity. Gronewold A; Horn M; Ranđelović I; Tóvári J; Muñoz Vázquez S; Schomäcker K; Neundorf I ChemMedChem; 2017 Jan; 12(1):42-49. PubMed ID: 27860402 [TBL] [Abstract][Full Text] [Related]
37. An unexpected cell-penetrating peptide from Bothrops jararaca venom identified through a novel size exclusion chromatography screening. Sciani JM; Vigerelli H; Costa AS; Câmara DA; Junior PL; Pimenta DC J Pept Sci; 2017 Jan; 23(1):68-76. PubMed ID: 28054409 [TBL] [Abstract][Full Text] [Related]
38. Thermodynamics of lipid interactions with cell-penetrating peptides. Sauder R; Seelig J; Ziegler A Methods Mol Biol; 2011; 683():129-55. PubMed ID: 21053127 [TBL] [Abstract][Full Text] [Related]
39. Cell-type specific penetrating peptides: therapeutic promises and challenges. Zahid M; Robbins PD Molecules; 2015 Jul; 20(7):13055-70. PubMed ID: 26205050 [TBL] [Abstract][Full Text] [Related]